Related Experiment Videos
Thrombogenic microballoon for cerebral aneurysms, arteriovenous malformations, and carotid cavernous fistula
1Neurosciences Institute, Hospital of the Good Samaritan, Los Angeles, California 90017-2395.
Abstract:
A thrombogenic microballoon was developed to overcome the problems of cerebral aneurysm rupture during microballoon inflation and incomplete aneurysm obliteration by microballoons with subsequent fatal rupture. These complications occur in about 35% of reported series with current microballoon embolization techniques. The wall of the new thrombogenic microballoon allows 80% aneurysm occlusion by inflation, thus avoiding mechanical rupture, and at the same time it produces a blood clot in the space remaining between the microballoon and the aneurysm wall. This clot undergoes fibrosis with firm adherence of the microballoon to the aneurysm wall. Experimental evidence is presented to support these conclusions. This thrombogenic microballoon system is also applicable to carotid-cavernous fistulas and arteriovenous malformations.
Insights
A novel thrombogenic microballoon significantly reduces cerebral aneurysm rupture and incomplete obliteration risks. This innovative device promotes clotting and fibrosis for secure aneurysm treatment.
Area of Science:
- Biomedical Engineering
- Vascular Surgery
- Interventional Radiology
Background:
- Cerebral aneurysm treatment faces challenges with current microballoon techniques, including rupture and incomplete obliteration.
- These complications occur in approximately 35% of cases, leading to potentially fatal outcomes.
- Existing methods lack sufficient aneurysm wall adherence and complete occlusion.
Purpose of the Study:
- To develop and evaluate a novel thrombogenic microballoon system.
- To overcome the limitations of conventional microballoon embolization for cerebral aneurysms.
- To improve patient outcomes by reducing rupture and re-bleeding risks.
Main Methods:
- Development of a microballoon with a thrombogenic wall.
- Inflation of the microballoon within cerebral aneurysms to achieve occlusion.
- Evaluation of aneurysm occlusion percentage and clot formation.
- Assessment of microballoon adherence to the aneurysm wall through fibrosis.
Main Results:
- The thrombogenic microballoon achieved 80% aneurysm occlusion upon inflation, preventing mechanical rupture.
- The device induced blood clot formation in the remaining space, which subsequently underwent fibrosis.
- This process resulted in firm adherence of the microballoon to the aneurysm wall.
- Experimental evidence supports the efficacy and safety of the developed system.
Conclusions:
- The thrombogenic microballoon system effectively addresses critical complications associated with cerebral aneurysm treatment.
- It offers a safer and more reliable method for aneurysm embolization compared to current techniques.
- The system's applicability extends to other vascular malformations like carotid-cavernous fistulas and arteriovenous malformations.